Microbiology Quiz: Protein Synthesis Inhibitors
20 questions · exam conditions
0:00
Protein Synthesis InhibitorsQuestion 1 of 20

A ribosome has just catalyzed peptide bond formation. This results in a peptidyl-tRNA occupying the A site and a deacylated tRNA in the P site. The addition of an antibiotic prevents the ribosome from shifting one codon down the mRNA. This antibiotic is most likely interfering with the function of what component?

The peptidyl transferase center of the 23S rRNA.
Elongation Factor G (EF-G) and its associated GTPase activity.
Initiation Factor 2 (IF2) in delivering the first tRNA.
The decoding center within the 16S rRNA.
← Back to quizzes

Microbiology Quiz

Microbiology Quiz: Protein Synthesis Inhibitors

Practice Protein Synthesis Inhibitors in Microbiology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Protein Synthesis Inhibitors, giving you a quick way to practice the rules, question types, and explanations that matter most for Microbiology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A ribosome has just catalyzed peptide bond formation. This results in a peptidyl-tRNA occupying the A site and a deacylated tRNA in the P site. The addition of an antibiotic prevents the ribosome from shifting one codon down the mRNA. This antibiotic is most likely interfering with the function of what component?

  1. The peptidyl transferase center of the 23S rRNA.
  2. Elongation Factor G (EF-G) and its associated GTPase activity. (correct answer)
  3. Initiation Factor 2 (IF2) in delivering the first tRNA.
  4. The decoding center within the 16S rRNA.
Explanation: The scenario describes a state immediately preceding translocation. The movement of the ribosome along the mRNA is an active process mediated by Elongation Factor G (EF-G), a GTPase. Antibiotics like macrolides and fusidic acid inhibit this translocation step. The peptidyl transferase center has just acted. IF2 is involved only in initiation. The decoding center is involved in ensuring correct tRNA binding at the A site, a step that has already occurred.

Question 2

A strain of Escherichia coli is treated with a sub-inhibitory concentration of an antibiotic. Subsequent analysis of the proteome reveals a significant proportion of non-functional enzymes containing incorrect amino acid sequences. This proteomic evidence is most consistent with the action of an antibiotic that targets which of the following?

  1. The 30S ribosomal subunit, interfering with codon-anticodon fidelity. (correct answer)
  2. The 50S ribosomal subunit, inhibiting the peptidyl transferase center.
  3. Elongation Factor G (EF-G), preventing its release from the ribosome.
  4. Isoleucyl-tRNA synthetase, preventing the charging of tRNA^Ile.
Explanation: The synthesis of proteins with incorrect amino acid sequences is a hallmark of mRNA misreading. Aminoglycosides, such as streptomycin and gentamicin, bind to the 16S rRNA of the 30S subunit. This binding causes a conformational change that decreases the fidelity of codon-anticodon pairing at the A site, leading to the incorporation of wrong amino acids. Inhibiting the peptidyl transferase center, EF-G, or tRNA synthetases would halt or slow protein synthesis rather than cause misreading.

Question 3

A clinical isolate of Staphylococcus aureus is found to be resistant to erythromycin due to an erm gene, which encodes an enzyme that methylates a specific adenine residue in the 23S rRNA. This single modification is most likely to confer cross-resistance to which other antibiotic?

  1. Clindamycin (correct answer)
  2. Gentamicin
  3. Doxycycline
  4. Linezolid
Explanation: Erythromycin (a macrolide) and clindamycin (a lincosamide) have overlapping binding sites on the 23S rRNA of the 50S ribosomal subunit. Methylation of this site by an Erm methyltransferase reduces the binding affinity for both drug classes, a phenomenon known as MLSB (Macrolide-Lincosamide-Streptogramin B) resistance. Gentamicin and doxycycline bind to the 30S subunit, and linezolid binds to a different site on the 50S subunit, so they would not be affected by this specific modification.

Question 4

An experimental antibiotic is found to halt bacterial protein synthesis. Biochemical assays reveal that it does not bind to the 30S or 50S ribosomal subunits, nor does it affect elongation factors. Instead, it acts as a competitive inhibitor for an enzyme responsible for attaching a specific amino acid to its cognate tRNA. This mechanism is most analogous to that of which existing antibiotic?

  1. Mupirocin (correct answer)
  2. Fusidic acid
  3. Quinupristin
  4. Tetracycline
Explanation: Mupirocin inhibits protein synthesis by specifically and reversibly binding to isoleucyl-tRNA synthetase. This prevents the charging of tRNA with isoleucine, leading to a depletion of the necessary building blocks for protein synthesis. The other antibiotics listed act directly on the ribosome (tetracycline, quinupristin) or on an elongation factor associated with the ribosome (fusidic acid).

Question 5

The antibiotic Synercid is a combination of two streptogramins, dalfopristin (streptogramin A) and quinupristin (streptogramin B). While individually bacteriostatic, they are bactericidal in combination. What is the molecular basis for this observed synergy?

  1. Dalfopristin binding induces a conformational change in the 50S subunit that increases the affinity of quinupristin for its target site. (correct answer)
  2. Dalfopristin inhibits an efflux pump that removes quinupristin, while quinupristin blocks the ribosome.
  3. Dalfopristin inhibits initiation and quinupristin inhibits elongation, blocking protein synthesis at two distinct stages.
  4. Dalfopristin binds to the 30S subunit and quinupristin binds to the 50S subunit, disabling the entire ribosome.
Explanation: The synergy of streptogramins A and B is a classic example of cooperative binding. Both bind to the 50S subunit. The binding of dalfopristin (A) causes a conformational change in the ribosome that dramatically increases the binding affinity of quinupristin (B). This stable, ternary complex is a more potent inhibitor of protein synthesis, leading to a bactericidal effect.

Question 6

During bacterial protein elongation, immediately after the translocation step is completed, the A site is empty and ready for the next tRNA. At this precise moment, the growing polypeptide chain, attached to its tRNA, is located in which ribosomal site?

  1. The P (Peptidyl) site (correct answer)
  2. The A (Aminoacyl) site
  3. The E (Exit) site
  4. The Shine-Dalgarno binding site
Explanation: The elongation cycle can be summarized as: 1) Aminoacyl-tRNA binds to A site. 2) Peptide bond forms, transferring the polypeptide to the A-site tRNA. 3) Translocation occurs, moving the peptidyl-tRNA from the A site to the P site, and the now-uncharged tRNA from the P site to the E site. Therefore, immediately after translocation, the peptidyl-tRNA is in the P site. The A site is where the tRNA was located before translocation.

Question 7

A spontaneous point mutation in the rpsL gene, which encodes the ribosomal protein S12, confers high-level resistance to streptomycin. How does this specific mutation prevent the antibiotic's action?

  1. It increases the activity of an efflux pump that exports aminoglycosides from the cytoplasm.
  2. It induces the expression of an enzyme that adenylates and inactivates streptomycin.
  3. It alters the 23S rRNA of the 50S subunit, the primary target of streptomycin.
  4. It prevents the binding of streptomycin to its target site on the 16S rRNA within the 30S subunit. (correct answer)
Explanation: When you encounter questions about antibiotic resistance mechanisms, focus on matching the specific gene mutation to its corresponding target and mode of action. Different antibiotics have distinct cellular targets, and resistance mutations typically alter those exact binding sites. Streptomycin belongs to the aminoglycoside family and specifically targets bacterial protein synthesis by binding to the 16S rRNA within the 30S ribosomal subunit. The rpsL gene encodes ribosomal protein S12, which is intimately associated with this 16S rRNA binding site. When a point mutation occurs in rpsL, it changes the S12 protein structure, which in turn alters the conformation of the 16S rRNA region where streptomycin normally binds. This conformational change prevents streptomycin from binding effectively, eliminating its ability to disrupt protein synthesis and kill the bacterium. Option A is incorrect because rpsL mutations don't affect efflux pumps - they alter the target site itself. Option B describes enzymatic inactivation (like aminoglycoside-modifying enzymes), but rpsL mutations work through target modification, not enzyme production. Option C incorrectly identifies the target as 23S rRNA in the 50S subunit, but streptomycin targets the 30S subunit's 16S rRNA. Remember this pattern: ribosomal protein gene mutations typically confer resistance by altering the antibiotic's binding site on rRNA, not by destroying the drug or pumping it out. For aminoglycosides like streptomycin, always think "30S subunit and 16S rRNA" as the primary target.

Question 8

A ribosome has just catalyzed peptide bond formation. This results in a peptidyl-tRNA occupying the A site and a deacylated tRNA in the P site. The addition of an antibiotic prevents the ribosome from shifting one codon down the mRNA. This antibiotic is most likely interfering with the function of what component?

  1. The peptidyl transferase center of the 23S rRNA.
  2. Elongation Factor G (EF-G) and its associated GTPase activity. (correct answer)
  3. Initiation Factor 2 (IF2) in delivering the first tRNA.
  4. The decoding center within the 16S rRNA.
Explanation: The scenario describes a state immediately preceding translocation. The movement of the ribosome along the mRNA is an active process mediated by Elongation Factor G (EF-G), a GTPase. Antibiotics like macrolides and fusidic acid inhibit this translocation step. The peptidyl transferase center has just acted. IF2 is involved only in initiation. The decoding center is involved in ensuring correct tRNA binding at the A site, a step that has already occurred.

Question 9

The ribosomal E site plays a role in the ejection of deacylated tRNA after translocation. A protein synthesis inhibitor whose action would preclude any tRNA molecule from ever reaching the E site during an entire round of translation from initiation must be acting on which step?

  1. Release of the termination factors at a stop codon.
  2. Translocation of the peptidyl-tRNA from the A to the P site.
  3. Peptide bond formation catalyzed by 23S rRNA.
  4. Binding of the first aminoacyl-tRNA to the A site. (correct answer)
Explanation: When analyzing protein synthesis inhibitors, you need to trace the pathway of tRNA movement through the ribosome: A site (aminoacyl) → P site (peptidyl) → E site (exit). The question asks which step, if blocked, would prevent any tRNA from ever reaching the E site during translation. The correct answer is D because if the first aminoacyl-tRNA cannot bind to the A site, translation essentially cannot begin in any meaningful way. Without this initial binding event, no tRNA molecules will progress through the ribosome to eventually reach the E site. It's like blocking the entrance to a assembly line - nothing gets processed. Let's examine why the other options are wrong. Option A (release of termination factors) occurs at the very end of translation, so many tRNAs would have already passed through the E site before reaching this step. Option B (translocation from A to P site) would still allow the first tRNA to eventually reach the E site, since translocation moves tRNA from P to E site as well. Option C (peptide bond formation) occurs after tRNA binding, so the first tRNA could still move through all three sites even if peptide bonds aren't forming. Remember that translation follows a strict sequential order. When a question asks about preventing something from happening "during an entire round of translation," look for the earliest possible step that could be blocked. The earlier the block, the more complete the prevention of downstream events.

Question 10

Fusidic acid inhibits bacterial protein synthesis by binding to Elongation Factor G (EF-G) only when it is associated with the ribosome. This interaction stabilizes the EF-G-GDP complex on the ribosome after GTP hydrolysis. This specific action directly prevents which of the following events?

  1. The hydrolysis of GTP by EF-G required for translocation.
  2. The release of the EF-G-GDP complex from the ribosome. (correct answer)
  3. The initial binding of the EF-G-GTP complex to the pre-translocation ribosome.
  4. The delivery of aminoacyl-tRNA to the A site by EF-Tu.
Explanation: The translocation cycle requires EF-G to bind to the ribosome, hydrolyze GTP to GDP, and then be released. Fusidic acid traps the EF-G-GDP complex on the ribosome, preventing its dissociation. Since the release of EF-G is required for the ribosome to be ready for the next round of elongation (i.e., for EF-Tu to bring in a new tRNA), protein synthesis is stalled. It does not prevent GTP hydrolysis; rather, it acts on the post-hydrolysis state.

Question 11

In a cell-free translation assay, a researcher observes that the first peptide bond successfully forms, creating a dipeptidyl-tRNA that is correctly positioned in the ribosomal A site. However, no further peptide bonds are formed, and the ribosome fails to move along the mRNA. This specific stall point suggests the presence of an antibiotic from which class?

  1. Tetracyclines
  2. Aminoglycosides
  3. Macrolides (correct answer)
  4. Oxazolidinones
Explanation: The scenario describes a block in translocation. After the first peptide bond is formed, the dipeptidyl-tRNA is in the A site. The next step, translocation, involves moving this tRNA to the P site to free the A site for the next aminoacyl-tRNA. Macrolides (e.g., erythromycin) bind to the 50S subunit and block the polypeptide exit tunnel, thereby inhibiting translocation. Tetracyclines would prevent the initial binding of the second tRNA to the A site. Oxazolidinones would prevent initiation entirely. Aminoglycosides would cause misreading or inhibit initiation.

Question 12

A microbiologist treats a bacterial culture with a novel antibiotic and then analyzes the cellular machinery using polysome profiling. The profile reveals a dramatic reduction in the peaks corresponding to polysomes and a large, corresponding increase in the peak for 70S monosomes. This result strongly suggests the antibiotic acts as an inhibitor of which process?

  1. Translation elongation
  2. Translation termination
  3. Translation initiation (correct answer)
  4. Ribosome biogenesis
Explanation: Polysomes are complexes of one mRNA with multiple ribosomes translating it simultaneously. An inhibitor of initiation prevents new ribosomes from loading onto mRNA. Ribosomes already on the mRNA will complete translation and fall off. This 'runoff' leads to the disassembly of polysomes and an accumulation of free, inactive 70S monosomes. In contrast, an elongation or termination inhibitor would 'freeze' ribosomes on the mRNA, preserving or even enhancing the polysome peaks.

Question 13

A bacterium acquires a plasmid carrying the tet(A) gene, which encodes a tetracycline-specific efflux pump. If this newly resistant strain is exposed to tetracycline, which of the following molecular events will occur at a rate most similar to that in an untreated, susceptible bacterium?

  1. Translocation of the peptidyl-tRNA from the A site to the P site.
  2. Formation of the 70S initiation complex.
  3. Binding of an incoming aminoacyl-tRNA to the ribosomal A site. (correct answer)
  4. Release of elongation factor Tu (EF-Tu) after GTP hydrolysis.
Explanation: Tetracycline's mechanism is to bind the 30S subunit and physically block the incoming aminoacyl-tRNA from binding to the A site. An efflux pump actively transports the tetracycline out of the cell, keeping its intracellular concentration below the inhibitory level. Therefore, the drug cannot reach its target. As a result, the very process that tetracycline inhibits—the binding of aminoacyl-tRNA to the A site—will proceed normally, at a rate similar to an untreated cell. The other processes listed are also part of normal translation but are not the direct step inhibited by tetracycline.

Question 14

A mid-log phase culture of susceptible E. coli is treated with a bacteriostatic concentration of doxycycline. After 4 hours, the cells are pelleted, washed thoroughly, and resuspended in fresh, antibiotic-free medium. Which of the following outcomes is most likely?

  1. The bacterial population will resume logarithmic growth after a brief lag phase. (correct answer)
  2. The population will continue to decline as the initial damage is irreversible.
  3. The cells will remain metabolically inert due to permanent inactivation of their ribosomes.
  4. The cells will lyse upon transfer to fresh medium due to compromised cell envelopes.
Explanation: Doxycycline, a tetracycline, is a bacteriostatic agent whose binding to the ribosome is reversible. When the antibiotic is removed from the environment, it dissociates from the ribosomes, which can then resume protein synthesis. This allows the bacteria to exit the static state and re-enter logarithmic growth. The other options describe outcomes expected from irreversible binding or bactericidal mechanisms.

Question 15

An experiment is designed to measure the incorporation of radiolabeled amino acids into polypeptides in a cell-free bacterial translation system. In the presence of a specific antibiotic, researchers observe that while 30S and 50S ribosomal subunits, mRNA, and charged tRNAs are all available, no stable 70S initiation complexes are formed on the mRNA template. This finding is most characteristic of which antibiotic?

  1. Tetracycline
  2. Linezolid (correct answer)
  3. Erythromycin
  4. Streptomycin
Explanation: Linezolid, an oxazolidinone, has a unique mechanism of action among protein synthesis inhibitors. It binds to the 23S rRNA of the 50S subunit and prevents its association with the 30S subunit-mRNA-fMet-tRNA complex. This directly inhibits the formation of the functional 70S initiation complex, which is consistent with the experimental observation. Tetracycline and Erythromycin act on already-formed 70S ribosomes during elongation. Streptomycin can interfere with initiation, but it does so by binding the 30S subunit and causing distortion, not by preventing the joining of the subunits.

Question 16

A bacterial strain acquires resistance to chloramphenicol via a plasmid-encoded chloramphenicol acetyltransferase (CAT). This enzyme modifies and inactivates the drug. This strain would most likely exhibit what susceptibility pattern to clindamycin, which also targets the peptidyl transferase center?

  1. Continued susceptibility, as the resistance mechanism is drug-specific. (correct answer)
  2. Cross-resistance, as both drugs bind to an overlapping site.
  3. Increased susceptibility, due to altered ribosome structure.
  4. Inducible resistance that appears only after chloramphenicol exposure.
Explanation: This question requires distinguishing between resistance via target modification and resistance via drug inactivation. Chloramphenicol acetyltransferase is an enzyme specific to the chemical structure of chloramphenicol. It will not recognize or modify clindamycin, which has a different structure. Therefore, even though the drugs have a similar target site on the ribosome, this specific resistance mechanism (enzymatic inactivation) will not confer cross-resistance. Cross-resistance would be expected if the mechanism was methylation of the 23S rRNA target site.

Question 17

Erythromycin binds within the polypeptide exit tunnel of the 50S ribosomal subunit. This steric hindrance is known to cause premature dissociation of the peptidyl-tRNA from the ribosome. This effect is most pronounced for polypeptides containing which type of sequence?

  1. A series of positively charged amino acids.
  2. A specific sequence of amino acids that interacts poorly with the tunnel wall.
  3. A stretch of small, nonpolar amino acids like glycine and alanine.
  4. Any polypeptide that exceeds a length of approximately 8-10 amino acids. (correct answer)
Explanation: The polypeptide exit tunnel can accommodate a short nascent chain. Macrolides like erythromycin act as a plug partway down this tunnel. Polypeptides can be synthesized until they reach a length of about 8-10 amino acids, at which point the growing chain physically collides with the bound antibiotic. This steric clash destabilizes the peptidyl-tRNA in the P site, causing it to dissociate, thus terminating translation prematurely. While specific sequences can modulate this effect, the primary mechanism is length-dependent obstruction.

Question 18

A strain of Escherichia coli is treated with a sub-inhibitory concentration of an antibiotic. Subsequent analysis of the proteome reveals a significant proportion of non-functional enzymes containing incorrect amino acid sequences. This proteomic evidence is most consistent with the action of an antibiotic that targets which of the following?

  1. The 30S ribosomal subunit, interfering with codon-anticodon fidelity. (correct answer)
  2. The 50S ribosomal subunit, inhibiting the peptidyl transferase center.
  3. Elongation Factor G (EF-G), preventing its release from the ribosome.
  4. Isoleucyl-tRNA synthetase, preventing the charging of tRNA^Ile.
Explanation: The synthesis of proteins with incorrect amino acid sequences is a hallmark of mRNA misreading. Aminoglycosides, such as streptomycin and gentamicin, bind to the 16S rRNA of the 30S subunit. This binding causes a conformational change that decreases the fidelity of codon-anticodon pairing at the A site, leading to the incorporation of wrong amino acids. Inhibiting the peptidyl transferase center, EF-G, or tRNA synthetases would halt or slow protein synthesis rather than cause misreading.

Question 19

In a cell-free translation assay, a researcher observes that the first peptide bond successfully forms, creating a dipeptidyl-tRNA that is correctly positioned in the ribosomal A site. However, no further peptide bonds are formed, and the ribosome fails to move along the mRNA. This specific stall point suggests the presence of an antibiotic from which class?

  1. Tetracyclines
  2. Aminoglycosides
  3. Macrolides (correct answer)
  4. Oxazolidinones
Explanation: The scenario describes a block in translocation. After the first peptide bond is formed, the dipeptidyl-tRNA is in the A site. The next step, translocation, involves moving this tRNA to the P site to free the A site for the next aminoacyl-tRNA. Macrolides (e.g., erythromycin) bind to the 50S subunit and block the polypeptide exit tunnel, thereby inhibiting translocation. Tetracyclines would prevent the initial binding of the second tRNA to the A site. Oxazolidinones would prevent initiation entirely. Aminoglycosides would cause misreading or inhibit initiation.

Question 20

An experimental antibiotic is found to halt bacterial protein synthesis. Biochemical assays reveal that it does not bind to the 30S or 50S ribosomal subunits, nor does it affect elongation factors. Instead, it acts as a competitive inhibitor for an enzyme responsible for attaching a specific amino acid to its cognate tRNA. This mechanism is most analogous to that of which existing antibiotic?

  1. Mupirocin (correct answer)
  2. Fusidic acid
  3. Quinupristin
  4. Tetracycline
Explanation: Mupirocin inhibits protein synthesis by specifically and reversibly binding to isoleucyl-tRNA synthetase. This prevents the charging of tRNA with isoleucine, leading to a depletion of the necessary building blocks for protein synthesis. The other antibiotics listed act directly on the ribosome (tetracycline, quinupristin) or on an elongation factor associated with the ribosome (fusidic acid).